Melinamide

This classification denotes an enzyme inhibitor with the molecular formula C26H41NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JJ07049A84, chemically known as 9,12-octadecadienamide, n-(1-phenylethyl)-, (z,z)- (9ci) but generally known as melinamide, which bears US NIH Compound Identifier 5282142. European Medicines Agency schedules Melinamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08724MIG. The term MELINAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). MELINAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule melinamide under HS 29242995 and SITC 51479. As of Q4 2014, MELINAMIDE remains the US FDA Preferred Term for this commodity. Melinamide bears US NLM identifiers UMLS ID C0067477 and NCI Concept Code C87732. SMILES: O=C(NC(c1ccccc1)C)CCCCCCC/C=C/C/C=C/CCCCC.